Pyrazinecarbonyl chloride, 5-methyl- (9CI)
- $106.04 - $488
- Product name: Pyrazinecarbonyl chloride, 5-methyl- (9CI)
- CAS: 50886-34-5
- MF: C6H5ClN2O
- MW: 156.57
- EINECS:
- MDL Number:MFCD13173590
- Synonyms:Pyrazinecarbonyl chloride, 5-methyl- (9CI);5-Methylpyrazine-2-carbonyl chloride;5-methyl-2-Pyrazinecarbonyl chloride;2-Pyrazinecarbonyl chloride, 5-methyl-
4 prices
Selected condition:
Brand
- Atlantic Research Chemicals
- Crysdot
- Matrix Scientific
Package
- 1g
- 1gm:
- 250mgs:
- ManufacturerAtlantic Research Chemicals
- Product numberCC01101
- Product description5-Methylpyrazine-2-carbonylchloride 95%
- Packaging250mgs:
- Price$106.04
- Updated2021-12-16
- Buy
- ManufacturerAtlantic Research Chemicals
- Product numberCC01101
- Product description5-Methylpyrazine-2-carbonylchloride 95%
- Packaging1gm:
- Price$166.12
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11113886
- Product description5-Methylpyrazine-2-carbonylchloride 97%
- Packaging1g
- Price$339
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number083179
- Product description5-Methylpyrazine-2-carbonyl chloride 97%
- Packaging1g
- Price$488
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Atlantic Research Chemicals | CC01101 | 5-Methylpyrazine-2-carbonylchloride 95% | 250mgs: | $106.04 | 2021-12-16 | Buy |
Atlantic Research Chemicals | CC01101 | 5-Methylpyrazine-2-carbonylchloride 95% | 1gm: | $166.12 | 2021-12-16 | Buy |
Crysdot | CD11113886 | 5-Methylpyrazine-2-carbonylchloride 97% | 1g | $339 | 2021-12-16 | Buy |
Matrix Scientific | 083179 | 5-Methylpyrazine-2-carbonyl chloride 97% | 1g | $488 | 2021-12-16 | Buy |
Properties
Boiling point :237.5±35.0 °C(Predicted)
Density :1.320±0.06 g/cm3(Predicted)
pka :-1.82±0.10(Predicted)
Density :1.320±0.06 g/cm3(Predicted)
pka :-1.82±0.10(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|